How Much Did PharMerica Raise?
Funding & Key Investors

PharMerica has successfully secured a major strategic investment, marking a significant milestone in its operational trajectory. The company has reached a cumulative capital position of $150M, with the most recent infusion of $150M serving to bolster its market-leading pharmacy management infrastructure. This influx of capital underscores the firm's critical role in the healthcare supply chain, particularly within the institutional care sector where precision and compliance are paramount.

What is PharMerica?

PharMerica
RetailDrug Stores & PharmaciesHealthcare Services

Headquartered in Louisville, Kentucky, PharMerica operates as a specialized provider of pharmacy management services tailored for skilled nursing facilities, long-term care centers, and hospitals. The company distinguishes itself through a robust service model that integrates medication delivery, rigorous cost containment strategies, and comprehensive regulatory compliance. By streamlining pharmaceutical logistics for institutional clients, PharMerica effectively mitigates the complexities associated with medication administration in high-acuity environments, positioning itself as an essential partner in the continuum of patient care across the United States.

How much funding has PharMerica raised?

PharMerica has raised a total of $150M across 1 funding round:

2016

Debt

$150M

Debt (2016): $150M with participation from Bank of America

Key Investors in PharMerica

Bank of America

Bank of America is a global financial services institution that provides a comprehensive range of banking, investment, asset management, lending, and risk management solutions to individuals, businesses, corporations, governments, and institutional clients.

What's next for PharMerica?

With the recent capital injection, PharMerica is well-positioned to scale its service offerings and enhance its technological capabilities in medication management. The strategic focus will likely shift toward optimizing supply chain efficiencies and expanding its footprint in the long-term care market. As the demand for specialized institutional pharmacy services continues to rise, the company is expected to leverage this financing to strengthen its competitive advantage, drive operational excellence, and further integrate its compliance-driven solutions into the broader healthcare ecosystem.

See full PharMerica company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Retail industry

Automobile DealersRetailAutomotive Service & Collision RepairConsumer Services
Flowers, Gifts & Specialty StoresRetailAuctionsDepartment Stores, Shopping Centers & Superstores
Ecommerce PlatformsRetail
Apparel & Accessories RetailRetailManufacturingTextiles & Apparel

Frequently Asked Questions Regarding PharMerica Financial Insights

What are the most recent funding rounds that PharMerica has completed, and what were the funding rounds?
PharMerica has recently completed 1 funding rounds: Debt on Dec 14, 2016.
What is the total amount of funding PharMerica has raised to date?
PharMerica has raised a total of $150M in funding to date.
How many funding rounds has PharMerica completed?
PharMerica has completed 1 funding rounds.
How much funding did PharMerica raise in its most recent funding round?
PharMerica raised $150M in its most recent funding round.
Who are the lead investors in PharMerica's latest funding round?
The lead investor in PharMerica's latest funding round was Bank of America. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PharMerica's history?
The largest funding round in PharMerica's history was $150M.
See more information about PharMerica